LLY

ELI LILLY & Co

US StockNYSEPharmaceutical Preparations

Research the business. Follow the filings.

Financial information from SEC disclosures, with reporting periods kept in context.

Revenue

65.2B USDAnnual · FY 2025

Net income

20.6B USDAnnual · FY 2025

Total assets

112.5B USDAnnual · FY 2025

Equity

26.5B USDAnnual · FY 2025

Operating cash flow

16.8B USDAnnual · FY 2025

Revenue growth

44.7%Annual · FY 2025

LLY · Chart

Chart provided by TradingView. Loading the chart connects your browser to TradingView and sends necessary technical information such as your IP address, page URL, and displayed symbol.

Reported financial information

Revenue

USD

65.2B USD

Period data
PeriodValue
FY 202128.3B USD
FY 202228.5B USD
FY 202334.1B USD
FY 202445B USD
FY 202565.2B USD

Operating income

USD

No applicable data available

No applicable data available

Net income

USD

20.6B USD

Period data
PeriodValue
FY 20215.6B USD
FY 20226.2B USD
FY 20235.2B USD
FY 202410.6B USD
FY 202520.6B USD

Total assets

USD

112.5B USD

Period data
PeriodValue
FY 202148.8B USD
FY 202249.5B USD
FY 202364B USD
FY 202478.7B USD
FY 2025112.5B USD

Equity

USD

26.5B USD

Period data
PeriodValue
FY 20219B USD
FY 202210.6B USD
FY 202310.8B USD
FY 202414.3B USD
FY 202526.5B USD

Operating cash flow

USD

16.8B USD

Period data
PeriodValue
FY 20217.4B USD
FY 20227.6B USD
FY 20234.2B USD
FY 20248.8B USD
FY 202516.8B USD

Revenue growth

%

44.7%

Period data
PeriodValue
FY 202115.4%
FY 20220.8%
FY 202319.6%
FY 202432%
FY 202544.7%

Operating income growth

%

No applicable data available

No applicable data available

Net income growth

%

94.9%

Period data
PeriodValue
FY 2021-9.9%
FY 202211.9%
FY 2023-16.1%
FY 2024102.1%
FY 202594.9%

Operating margin

%

No applicable data available

No applicable data available

Net margin

%

31.7%

Period data
PeriodValue
FY 202119.7%
FY 202221.9%
FY 202315.4%
FY 202423.5%
FY 202531.7%

Return on assets

%

21.6%

Period data
PeriodValue
FY 202111.7%
FY 202212.7%
FY 20239.2%
FY 202414.8%
FY 202521.6%

Debt/Equity

x

No applicable data available

Period data
PeriodValue
FY 2021N/A
FY 2022N/A
FY 2023N/A
FY 2024N/A
FY 2025N/A